Clinical Trial Update: Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of methotrexate and thiotepa for newly diagnosed primary central nervous system lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: New Approaches to Brain Tumor Therapy Consortium | Conditions: Lymphoma | Phase 2 | Status: COMPLETED